Beyond CSU, Jasper Therapeutics believes that briquilimab could address other chronic and mast cell-driven diseases with unmet treatment needs such as chronic inducible urticaria, asthma, COPD, ...
In 2024, the FDA approved at-home blood and stool tests for colorectal cancer screenings. In October, a second iteration of the at-home stool test was approved. While new, less-invasive blood tests ...